Looking For A Top Momentum Stock? Why Clover Health Investments Corp (NASDAQ: CLOV) Is A Great Pick

Clover Health Investments Corp (NASDAQ:CLOV) shares, rose in value, with the stock price down by -0.22% to the previous day’s close as strong demand from buyers drove the stock to $0.75.

Actively observing the price movement in the last trading, the stock closed the session at $0.76. The value of beta (5-year monthly) was 1.86. Referring to stock’s 52-week performance, its high was $1.63, and the low was $0.71. On the whole, CLOV has fluctuated by -6.44% over the past month.

With the market capitalization of Clover Health Investments Corp currently standing at about $372.60 million, investors are eagerly awaiting this quarter’s results, scheduled for May 07, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.07, which is expected to increase to -$0.03 for fiscal year -$0.22 and then to about -$0.2 by fiscal year 2025. Data indicates that the EPS growth is expected to be 50.00% in 2025, while the next year’s EPS growth is forecast to be 9.10%.

Analysts have estimated the company’s revenue for the quarter at $321.23 million, with a low estimate of $316.1 million and a high estimate of $325.59 million. According to the average forecast, sales growth in current quarter could jump down -39.10%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $1.28 billion, representing a decrease of -37.30% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CLOV’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CLOV currently trading nearly -4.97% and -14.85% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.19, while the 7-day volatility ratio is showing 5.61% which for the 30-day chart, stands at 6.39%. Furthermore, Clover Health Investments Corp (CLOV)’s beta value is 1.84, and its average true range (ATR) is 0.05.

A comparison of Clover Health Investments Corp (CLOV) with its peers suggests the former has fared considerably weaker in the market. CLOV showed an intraday change of -0.22% in last session, and over the past year, it shrunk by -11.11%%.

Data on historical trading for Clover Health Investments Corp (NASDAQ:CLOV) indicates that the trading volumes over the past 10 days have averaged 8.64 million and over the past 3 months, they’ve averaged 9.37 million. According to company’s latest data on outstanding shares, there are 393.27 million shares outstanding.

Nearly 24.03% of Clover Health Investments Corp’s shares belong to company insiders and institutional investors own 19.64% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 47.54 million shares as on Mar 15, 2024, resulting in a short ratio of 3.45. According to the data, the short interest in Clover Health Investments Corp (CLOV) stood at 9.60% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 29.52 million. The stock has fallen by -20.70% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CLOV stock heading into the next quarter.

Most Popular